Tower Research Capital LLC (Trc) Aslan Pharmaceuticals LTD Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.74 - $1.22 $148 - $244	-200 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $933 - $1,564	-841 Reduced 80.79%	200 $0
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $1,852 - $3,549	1,041 New	1,041 $2,000
Q3 2019 Nov 05, 2019	SELL	$1.51 - $3.85 $394 - $1,004	-261 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.91 - $4.5 $759 - $1,174	261 New	261 $1,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.